Raktamoola: Benefits, Evidence & Safety

TL;DR

Raktamoola ("red root") is a Sanskrit synonym of Lajjalu: Mimosa pudica, the touch-me-not plant whose leaves fold on contact. Ayurvedic texts group it with wound-healing and stool-binding herbs and use it for wounds, piles and diarrhea. Animal and lab studies report wound-healing, anxiolytic and anti-inflammatory activity, but the reviewers found no human clinical trials at all. (57 words. Sources: Adurosakin et al., Pharmacol Res Mod Chin Med 2023; Ayurvedic materia medica.)

What it is

Raktamoola literally means "red root": it is a Sanskrit synonym of Lajjalu, the touch-me-not plant Mimosa pudica Linn. (family Fabaceae, subfamily Mimosoideae), named for its coppery-red roots (easyayurveda: Lajjalu monograph). It is the small creeping herb famous for folding its leaves when touched. The whole plant is used in Ayurvedic practice, with the root as the part implied by the name Raktamoola. A 2023 peer-reviewed review confirms its taxonomy and its use across ethnomedicine for diarrhea, dysentery, diabetes, wounds and urinary complaints (Adurosakin et al., Pharmacological Research: Modern Chinese Medicine 2023).

Note: "Raktamoola" is a descriptive synonym, not a separate species: it should not be confused with Manjistha (Rubia cordifolia), another red-rooted Ayurvedic herb.

Traditional use

In the classical categorisation, Lajjalu sits in Charaka's Sandhaniya group (herbs for wound and fracture healing) and the Purisha-sangrahaneeya group (herbs that bulk the stool), and in the Priyangvadi gana of Sushruta and Vagbhata (easyayurveda; peer-reviewed review of Lajjalu, JETIR 2022). Traditional practice uses it mainly for wounds, piles, diarrhea and dysentery, uterine prolapse, and bleeding conditions. The 2023 review records the same spectrum of ethnomedicinal use across Asia and Africa (Adurosakin et al. 2023). These are traditional and ethnomedicinal claims: the modern evidence is assessed separately below.

What modern research says

Wound healing — animal studies only

In-vivo (animal) studies found that M. pudica extracts promoted wound healing, consistent with its Sandhaniya grouping in the classical texts (Adurosakin et al. 2023). No human wound-healing trial exists.

Anxiolytic (anti-anxiety) activity — animal studies only

Animal behavioural studies reported anxiolytic and sedative-like activity for M. pudica extracts (Adurosakin et al. 2023). These are rodent findings, not evidence it relieves anxiety in people.

Anti-inflammatory and antioxidant activity — lab and animal studies

In-vitro and in-vivo studies reported anti-inflammatory, antioxidant and antimicrobial activity, attributed to the plant's flavonoids, tannins and other bioactive compounds (Adurosakin et al. 2023).

Antidiabetic and other reported activities — preclinical

Antidiabetic, hepatoprotective, antimalarial, anthelmintic and anticancer activities have all been reported: every one of them in cell or animal systems, not in human trials (Adurosakin et al. 2023).

The honest gap

The 2023 reviewers state it plainly: **no clinical trial and no quality-control studies of Mimosa pudica exist in the literature**, and they recommend proper trials before any safe, effective dose can be established (Adurosakin et al. 2023). Every pharmacological claim above is preclinical.

Safety & contraindications

There are no published human safety data for Raktamoola/Lajjalu as a medicine: safety data are limited, so talk to a clinician before use. Two points deserve honest flagging: the 2023 review documents antifertility activity in animal studies, which is a reason to avoid medicinal use when trying to conceive or during pregnancy unless a qualified practitioner advises otherwise (Adurosakin et al. 2023). And because the reviewers found no quality-control studies, the identity and purity of market material cannot be taken for granted.

FAQs

What does "Raktamoola" mean?

It is Sanskrit for "red root": a descriptive synonym of Lajjalu (Mimosa pudica), referring to the plant's coppery-red roots (easyayurveda). It is a name describing a plant part's appearance, not a separate species: and it should not be confused with Manjistha (Rubia cordifolia), another red-rooted Ayurvedic herb with different uses.

Is Raktamoola the same as Manjistha?

No. Manjistha is Rubia cordifolia, a climbing plant whose red roots are used mainly for skin and blood-related conditions in Ayurveda. Raktamoola is a synonym of Lajjalu (Mimosa pudica), the touch-me-not plant: a different species, a different family, and a different set of classical indications (easyayurveda).

Are there any human trials on Raktamoola?

None. A 2023 peer-reviewed review covering the literature from 2001 to 2022 found no clinical trials and no quality-control studies of Mimosa pudica at all, and its authors explicitly recommended proper trials before any safe, effective dose could be established (Adurosakin et al. 2023). Every reported pharmacological activity, wound healing, anxiolytic, antidiabetic, comes from cell or animal work.

Can it heal wounds?

Animal studies found wound-healing activity for M. pudica extracts, which matches its classical placement in Charaka's Sandhaniya (wound-healing) group (Adurosakin et al. 2023; easyayurveda). But animal wound models are a long way from human proof: without any human trial, there is no evidence-based answer to whether it heals wounds in people.

Is it safe in pregnancy?

No human safety data exist, and the 2023 review documents antifertility activity in animal studies: a specific reason for caution (Adurosakin et al. 2023). Medicinal use should therefore be avoided in pregnancy and when trying to conceive unless a qualified practitioner advises otherwise. As with any herb, tell your doctor about all medicines and supplements you take.

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.